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The 2013 revision of the Declaration of Helsinki stated 
that “Medical research involving human subjects must be 
conducted only by individuals with the appropriate ethics 
and scientific education, training and qualifications.”
1
 
Considerable efforts to train principal investigators have 
been made through NIH funding mechanisms such as the 
Clinical Research Curriculum Awards to academic 
medical centers (K30 programs), as well as individual 
training awards such as the K08 or K23, and now the K99 
mechanism.
2
 At the same time, professional organizations 
such as the Association of Clinical Research 
Professionals (ACRP) and the Society for Clinical 
Research Administrators (SoCRA) provide educational 
opportunities for clinical research professionals as well as 
opportunities for certification as coordinators, monitors, 
etc. In addition, a number of for-profit companies offer 
ABSTRACT 
 
Background: Clinical research in the 21
st
 century will require a well-trained workforce to ensure that research 
protocols yield valid and reliable results. Several organizations have developed lists of core competencies for clinical 
trial coordinators, administrators, monitors, data management/informaticians, regulatory affairs personnel and others.  
Methods: We used data collected by the joint task force on the harmonization of core competencies from a survey of 
research professionals working in the US and Canada to create competency Indices for clinical research professionals. 
Respondents reported how competent they believed themselves to be on 51 clinical research core competencies.  
Results: Factor analyzes identified 20 core competencies that defined a competency index for clinical research 
professionals—general (CICRP-General, i.e., GCPs) and four sub-indices that define specialized research functions: 
Medicines Development; Ethics and Participant Safety; Data Management; and Research Concepts.   
Conclusions: These indices can be used to gage an individual‟s readiness to perform general as well as more 
advanced research functions; to assess the education and training needs of research workers; and to evaluate the 
impact of education and training programs on the competency of research coordinators, monitors and other clinical 
research team members. 
 
Keywords: Core competence, Clinical research professional, Self-efficacy, Factor analysis, Competency index, 
Workforce development 
1
Consortium of Academic Programs in Clinical Research, 
2
School of Medicine, University of Louisville, USA 
3
School of Nursing, Ohio State University, Ohio, USA 
4
Institute for Social Research, 
8
College of Pharmacy, University of Michigan, Michigan, USA 
5
School of Nursing, University of North Carolina at Wilmington, North Carolina, USA 
6
School of Health Sciences, Eastern Michigan University, Michigan, USA 
7
Academy of Medical-Surgical Nurses, USA 
 
Received: 11 October 2017 
Accepted: 25 November 2017 
 
*Correspondence: 
Mr. Carlton A. Hornung, 
E-mail: cahornung@louisville.edu 
 
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under 
the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial 
use, distribution, and reproduction in any medium, provided the original work is properly cited. 
DOI: http://dx.doi.org/10.18203/2349-3259.ijct20180130 
Hornung CA et al. Int J Clin Trials. 2018 Feb;5(1):46-53 
                                                           International Journal of Clinical Trials | January-March 2018 | Vol 5 | Issue 1    Page 47 
on-line and short courses for individuals in differing roles 
in the clinical research enterprise.  
Insuring the continued integrity of clinical and 
translational research in the 21st century will require 
refining existing training programs and developing new 
education and training opportunities for the clinical 
research workforce; particularly for trial coordinators, 
monitors, regulatory affairs specialists, data 
managers/informaticians as well as for investigators and 
those that design clinical trials.
3
 The era of precision 
medicine is beginning to replace the randomized, double 
blind, placebo controlled parallel group trial that utilizes 
two-tailed testing at the alpha.05 level in an intention-to-
treat analysis, the bedrock of clinical trial design, with 
innovative designs that test equivalence or non-inferiority 
and by designs that increase trial efficiency by reducing 
costs and/or by shortening time to a decision).
4
 For 
instance, adaptive designs, such as sequential multiple 
assignment randomized trials (SMART), involve 
individualized treatment regimens and decision rules that 
include group sequential statistical methods of analysis 
that control the type I error rate and guide alterations in 
the type or intensity of treatment depending upon patient 
outcomes. These trials present challenging and 
complicated problems for study coordinators, monitors 
and data managers who recruit participants, obtain their 
informed consent, manage data collection and conduct 
patient education and follow-up. Further, newer trials 
often include patient reported outcomes collected via 
various electronic monitoring devices and utilize web-
based evaluation tools. Disease registry-based 
randomized trials and community-based epidemiologic 
studies are being used more frequently either as stand-
alone research or in conjunction with practice-based 
pragmatic trials which, in contrast to explanatory trials, 
are designed to provide evidence for adopting or not 
adopting an intervention in “real world clinical practice.”
5
 
These pragmatic trials create special regulatory and 
ethical issues, especially in terms of informed consent, 
that were the topics of a special issue of the Journal of 
Clinical Trials in 2015.
6
 Similarly, trials that assess the 
comparative effectiveness of two or more interventions or 
therapies that are integrated into routine patient care can 
present additional challenges to data managers who may 
be required to integrate trial outcome data that is unique 




Adding to problems posed by the increasing complexity 
of pragmatic and comparative effectiveness studies is the 
fact that they are done in the real world clinical 
environment often with non-clinical research staff and 
sub-investigators who may lack formal training in clinical 
research procedures. Economic pressures can further 
complicate real-world trials when untrained or minimally 
trained staffs are required to manage a clinical study in 
addition to their primary care duties.  
Several clinical research organizations have produced 
lists of knowledge, attitudes and skills they propose to be 
the core competencies for clinical research for members 
of their organizations. The Consortium of Academic 
Programs in Clinical Research (CoAPCR), formed in 
2003 by directors of academic clinical research degree 
granting programs, consolidated the core competencies 
from these groups to create curricula to best prepare the 
next generation of clinical research professionals.
8
 Efforts 
to further define core competencies for clinical research 
professionals progressed when representatives from 
professional organizations, academic institutions, contract 
research organizations, and the pharmaceutical industry 
met at the Multi-Regional Clinical Trial Center (MRCT) 
at Harvard University in 2013. A result of this meeting 
was the formation of the Joint Task Force (JTF) for 
Clinical Trial Competency.  
The JTF set out to harmonize the core competency 
statements offered by the different organizations. The 
content analysis done by the JTF of the core 
competencies offered by the different organizations 
identified 8 theoretical competency domains containing 
51 core competencies. The eight domains were: 1) 
Scientific Concepts and Research Design; 2) Ethical and 
Participant Safety Considerations; 3) Medicines 
Development and Regulation; 4) Clinical Trials 
Operations (GCPs); 5) Study and Site Management; (6) 
Data Management and Informatics; 7) Leadership and 
Professionalism; and 8) Communication and Teamwork.
9
 
The JTF then conducted an international survey of 
clinical research professionals to assess their perceptions 
of competence and relevance of the JTF competencies to 
their clinical research roles.
10
 
The need for a competent clinical research workforce also 
led to the enhancing clinical research professionals 
training and qualifications (ECRPTQ) project lead by 
Thomas Shanley, MD and funded by the National Center 
for Advancing Translational Science (UL1TR000433-
08S1). Shanley and colleagues, with the participation of 
several organizations representing clinical research 
professionals (e.g., ACRP, ACI Clinical, & CoAPCR), 
led this Clinical and Translational Science Awards 
(CTSAs) consortium-wide effort to develop 
recommendations for training the clinical research 
workforce including physician investigators. 
Representative from 63 CTSA hubs provided input to 
identify a comprehensive set of role-based competencies 
within the domain framework suggested by the JTF.
11
 
Identifying the core competencies for clinical research 
professionals is only the first step in ensuring a qualified 
workforce. It is also necessary to assess the readiness of 
research coordinators, monitors, and other professionals 
to perform their designated roles. And, as Speicher and 
colleagues note, it is important to assess the not only the 
preparation of entry level workers but also the career 
development opportunities and continuing education 
requirements of more experienced professionals.
12
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In 2007, Mullikin, Bakken & Betz developed an 
assessment tool that sought to measure clinical research 
self-efficacy amongst physicians training for clinical 
research careers.
13
 They developed the Clinical Research 
Assessment Inventory (CRAI) using 92 items from 10 
competency domains that assessed the self-confidence of 
respondents in performing common tasks in clinical 
research. A total of 210 participants completed the online 
inventory. After factor analyses, the tool was reduced to 
88 items. This tool provided insights for curriculum 
development for training K-30 awardees. Subsequent 
studies sought to develop and test shorter versions of the 
CRAI that were less cumbersome to complete. For 
example, a study at Washington University sought to 
evaluate Clinical Research Training Programs using a 76-
item CRAI which, after factor analysis, resulted in a 
small reduction to 69 items. This study demonstrated 
significant improvements in self-efficacy as a result of 
participation in training.
14
 Later, a group led by Robinson 
from the University of Pittsburgh Institute for Clinical 
Research Education factor analyzed 92 core competency 
items that produced six factors with the 2 highest loading 
items on each factor used to create a shortened version—
the CRAI-12.
15
 The short-form CRAI was used to 
measure perceived self-efficacy of undergraduate and 
first year graduate nursing students and to assess eight 
cohorts of medical students' perceptions and interest in 
clinical research careers.
16,17
 One of us (JK) has been 
testing the use of a CRAI-SF (44 items, six domains) in 
undergraduate and graduate students enrolled in a clinical 
research curriculum. 
CRAI and the shorter form CRAI-12 is based upon self-
efficacy theory that argues that if individuals feel 
confident that they can complete a task and perform a 
role successfully, then they are more likely to actually do 
so and on social cognitive career theory that being able to 
do something successfully is associated with an increased 
likelihood of pursuing a role involving those activities.
18
 
While CRAI and its shortened form assess physician 
scientist‟s self-efficacy in the role of clinical investigator 
and translational scientist, no comparable index or 
instrument currently exists to assess the self-efficacy of 
clinical research professionals who perform roles in 
implementing and managing clinical research studies. 
Using data from the survey conducted by the JTF, we 
sought to develop such an index.
9 
METHODS 
The JTF conducted an on-line survey from December 12, 
2014 to July 1, 2015 in the United States (US), Canada, 
Latin American, Europe, Asia/Pacific, Middle East and 
Africa. The survey instrument was reviewed and 
approved by the University of Eastern Michigan IRB. 
Respondents were asked how competent they feel they 
were with carrying out each of the 51 JTF core 
competencies. Respondents were also asked how 
„significant‟ they felt each core competency was in the 
performance of their role in the clinical research 
enterprise and whether they thought they could benefit 
from additional training in each core competency.  
We conducted a secondary analysis that focused on the 
competency questions (University of Michigan IRB 
review and designation as „not regulated‟). Responses: 
“Competent—Able to interpret or discuss concepts and 
use knowledge to solve simple problems based on 
application concepts” and “Mastery—Able to apply 
knowledge to complex problems, integrate information, 
and create solutions” were combined to indicate that the 
respondent felt “Competent” to perform the specific 
clinical research function (i.e., the core competency). In 
contrast, the responses “Never been exposed to this 
content” (i.e., core competency), “Aware of the content, 
but never needed to become further informed” and 
“Exposed and sufficiently aware of content that I can 
look up what might be necessary for my role” were 
combined to indicate that the respondent lacked sufficient 
mastery of the material to claim to be competent.
8
  
Our factor analyses of the competency questions utilized 
only the data from participants in the US and Canada who 
reported their role in the clinical research process was 
coordinator, monitor, regulatory affairs, data manager or 
research administrator (Table 1). We deleted from the 
analysis respondents from outside the US and Canada to 
minimize possible confusion over role definitions as well 
as language differences. We also eliminated respondents 
who said they were principle investigators or physician or 
pharmaceutical scientists. Finally, we deleted two 
competencies items from the JTF scientific concepts and 
research design domain: (item 1 “Demonstrate 
knowledge of pathophysiology, pharmacology and 
toxicology as they relate to medicines discovery and 
development” and item 2 “Identify clinically important 
questions that are potentially testable clinical research 
hypothesis through review of the professional literature”). 
These items were deleted from the analysis because we 
felt they were not competencies expected of trial 
administrators, coordinators or monitors who constitute 
the clinical trial workforce of interest here. 
Table 1: JTF study participants’ role in the US and 
Canada Clinical Research Enterprise. 
Role N % 
Clinical research coordinator 83 34.9 
Clinical research monitor 26 34.9 
Data management 23 9.7 
Regulatory affairs 23 9.7 
Research administration 83 34.9 
Total 238 100 
We performed an identical exploratory factor analysis of 
the 49 remaining items to that done by Robinson, et al to 
create a hypothesized “Competency Index for Clinical 
Research Professionals” (CICRP) that would be 
equivalent to the CRAI for physicians aspiring to be 
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clinician scientists.
15
 All statistical analysis was 
performed using SPSS-Version 22. 
RESULTS 
The 49 core competencies yielded nine principal 
components with eigenvalues greater than one. These 
principal components closely paralleled the theoretical 
competency domains described by Sonstein et al for the 
JTF as well as those described by the Enhancing Clinical 
Research Professionals‟ Training and Qualifications 
group.
10,12
 We scanned the structure matrix (Promax 
rotation; Kappa=5) to identify the most important 
competencies defining each component that would enable 
us to reduce the number of items necessary to create a 
shorter, more easily administered survey instrument. We 
identified the two highest loading items on each of the 
nine factors and included two additional items from the 
Medicines Development factor that had loadings of 0.797 
and 0.792 respectively yielding a total of 20 core 
competencies. 
We performed a second-order factor analysis of these 20 
items (Promax rotation, Kappa=5) that created five 
second-order factors or empirical domains (in contrast to 
the theoretical domains derived by the JTF content 
analysis). The structure matrix showed that ten core 
competencies pertaining to the “General Operation and 
Management of Clinical Trials” clearly defined the first 
empirical domain. This is a general domain consisting of 
knowledge, skills and behaviors (e.g., GCPs) that all 
professionals, including entry level employees, working 
in the clinical trial enterprise could/should be expected to 
be competent to perform. In contrast to this general 
domain, the remaining four factors or domains pertain to 
more advanced knowledge and skills related to 
specialized aspects of clinical and translational research 
activities. Specifically, the second empirical domain is 
defined by five core competencies that reference the rules 
and processes governing “Medicines Development”. The 
third domain relates specifically to “Clinical Trial Ethics 
and Participant Safety” (five items) while the fourth 
domain is defined by five items that pertain to “Data 
Collection and Management”. The fifth and final domain 
is defined by five items pertaining to “Research 
Concepts” (i.e., Epidemiology and Biostatistics) that 
guide the design of scientifically sound and valid clinical 
trial protocols. Many of the core competencies are 
expressed in two or more of these empirical domains as 
shown in Table 2.  
Table 2: Competencies by empirical domain. 
Empirical domain Competencies 
I. General operation 
and management of 
clinical trials  
1. Describe the role and process for monitoring a study. 
2. Identify the legal responsibilities, issues liabilities and accountability that are involved 
in the conduct of a clinical trial. 
3. Describe the significance of data quality assurance systems and how SOPs are used to 
guide these processes. 
4. Compare and contrast the regulations and guidelines of global regulatory bodies relating 
to the conduct of clinical trials.  
5. Describe the reporting requirements of global regulatory bodies relating to clinical trial 
conduct. 
6. Compare and contrast clinical care and clinical management of research participants. 
7. Define the concepts of “clinical equipoise” and “therapeutic misconception” as they 
relate to the conduct of a clinical trial. 
8. Apply management concepts and effective training methods to manage risk and 
improve quality in the conduct of a clinical research study. 
9. Identify and apply the professional guidelines and codes of ethics which apply to the 
conduct of clinical research. 
10. Describe the impact of cultural diversity and the need for cultural competency in the 
design and conduct of clinical research. 
II. Medicines 
development 
1. Describe the roles and responsibilities of the various institutions participating in the 
medicines development process. 
2. Explain the medicines development process and the activities which integrate 
commercial realities into the life cycle management of medical products. 
3. Summarize the legislative and regulatory framework which supports the development 
and registration of medicines, devices and biologicals and esures their safety, efficacy 
and quality. 
4. Describe the specific processes and phases which must be followed in order for the 
regulatory authority to approve the marketing authorization for a medical product. 
5. Differentiate the types of adverse events which occur during clinical trials, understand 
the identification process for AEs and describe the reporting requirements to IRBs/IECs, 
sponsors and regulatory authorities. 
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Empirical domain Competencies 
III. Ethics and 
participant safety 
1. Compare and contrast clinical care and clinical management of research participants. 
2. Compare the requirements for human subject protection and privacy under different 
national and international regulations and ensures their implementation throughout all 
phases of a clinical study. 
3. Describe the ethical issues involved when dealing with vulnerable populations and the 
need for additional safeguards. 
4. Differentiate the types of adverse events which occur during clinical trials, understand 
the identification process for AEs and describe the reporting requirements to IRBs/IECs, 
sponsors and regulatory authorities. 
5. Describe the role and process for monitoring of the study. 
IV. Data collection and 
management 
1. Summarize the process of electronic data capture (EDC) and the importance of 
information technology in data collection, capture and management. 
2. Describe the significance of data quality assurance systems and how SOPs are used to 
guide these processes. 
3. Describe the reporting requirements of global regulatory bodies relating to clinical trial 
conduct. 
4. Identify and apply the professional guidelines and codes of ethics which apply to the 
conduct of clinical research. 
5. Describe the impact of cultural diversity and the need for cultural competency in the 
design and conduct of clinical research. 
V. Scientific concepts 
in clinical research 
1. Explain the elements (statistical, epidemiological and operational) of clinical and 
translational study design. 
2. Critically analyze study results with an understanding of therapeutic and comparative 
effectiveness Compare and contrast clinical care and clinical management of research 
participants. 
3. Compare and contrast clinical care and clinical management of research participants. 
4. Compare and contrast the regulations and guidelines of global regulatory bodies relating 
to the conduct of clinical trials.  
5. Describe the reporting requirements of global regulatory bodies relating to clinical trial 
conduct. 












    
Medicines development 0.63 1 
   
Ethics and participant safety 0.76 0.63 1 
  
Data management 0.87 0.50 0.57 1 
 
Research concepts 0.81 0.56 0.64 0.69 1 
Cronbach’s α 0.79 0.84 0.80 0.78 0.70 
RFactor, Index**  0.98 0.98 0.97 0.89 0.85 
Mean 5.44 2.58 3.87 3.06 1.96 
Std. deviation 3.15 1.84 1.51 1.71 1.68 
* Correlation between the factor score (20 core competencies; mean of zero, unit variance) and the summated competency index (0 to 10 
general index; or 0 to 5 sub indices). 




Med. Dev. Ethics and safety Data Mngt. 
Research 
concepts 
 CRC 83 5.65 2.51 4.22 3.17 2.02 
 CRA 26 6.00 3.27 4.56 3.42 2.50 
 Data Mngr. 23 3.52 1.70 2.48 2.79 1.34 
 Reg. Affairs. 23 5.04 3.21 4.00 2.43 1.78 
 Res. Adm. 83 5.70 2.50 3.63 3.10 1.95 
 P Value 0.029 0.016  0.000 0.267 0.191 
Note: General Comp. = General clinical trials operation and management; Med. Dev‟t = Medicines development; Ethics & Safety = 
Ethics and participant safety; Data Mgt.= Data collection and management; Research concepts = Scientific concepts in clinical research. 
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We summed the “Competent” responses for the items 
shown in Table 2 to create shorter and thereby easier to 
administer measure of competency for each of these 
domains. The summated Competency Index for Clinical 
Research Professionals (CICRP-General) from the first 
domain involving ten competencies is an index of 
competence in performing the general operations and 
management of clinical trials that sponsors and 
investigators might expect or require for entry level 
workers. Summing the responses for the five 
competencies defining domain two yields CICRP-
Medicines Development. Similarly summing the 
responses for the competencies defining domains three, 
four and five yields: CICRP-Ethics and Participant 
Safety; CICRP-Data Management; and CICRP-Research 
Concepts respectively. Each of these five-item indices 
assess competence in specialized clinical research core 
competencies that may be expected of more highly 
trained or experienced workers.  
Table 3 shows high correlations between the CICRP-
General and each of the CICRP specialty indices (an 
outcome of promax rotation). More importantly, there are 
high correlations between each CICRP specialty index 
with its parent factor score (i.e., involving all 20 
competency items) which indicates that each of the 
indices has a high degree of content and face validity 
which is confirmed by Cronbach‟s Alpha (Table 3). 
In Table 4 are the mean scores on each index according to 
the respondent‟s role in the clinical research enterprise. 
There are statistically notable differences across roles in 
CICRP-General, CICRP-Medicines Development and 
especially in competency involving CICRP-Ethics and 
Participant Safety. Respondents who report their role as 
clinical research monitor report the highest competency 
to perform functions related to Ethics and Participant 
Safety (mean=4.56) while respondents involved in data 
management score poorly on this index (mean=2.48). It is 
noteworthy that even those respondents who report their 
research roles involve data management and those who 
say their role is in regulatory affairs have low scores on 
the CICRP-Data Management index and on the CICRP-
Research Concepts index meaning that few respondents 
in these roles feel competent to perform these research 
functions. 
DISCUSSION 
These results reveal notable differences in self-reported 
competency to perform different clinical research 
functions across self-declared roles in the existing clinical 
research enterprise. The ad hoc nature of clinical research 
often engenders role confusion among those involved in 
practice.
19
 Job titles and roles vary across research sites 
and especially between real world clinical sites and 
academic institutions. Considerable work is needed to 
standardize job titles and their associated role 
expectations.
20,21 
Clarifying job titles and performance 
expectations across the clinical research enterprise is a 
necessary first step to develop the education and training 
programs necessary to prepare the clinical research 
workforce for 21
st
 century clinical trials.  
Regardless of current role ambiguity, scores on the 
CICRP-General and CICRP special indices can be used 
by sponsors and investigators to select individuals for 
defined roles in a clinical trial with the belief that an 
individual who is confident that she/he can competently 
carry out a role will be more likely to succeed at that role 
than an individual who lacks self-confidence in their 
ability. At the same time the directors of education and 
training programs can use these competency indices to 
assess educational needs of novice as well as more 
experienced workers. Educators and trainers can use pre-
and post-test evaluation measures to gage the impact of 
their curricula, training and mentoring activities on the 
self-confidence of students. Such data can be of 
considerable value in guiding competency-based 
curriculum and training reforms—a must have to insure 
the quality of 21
st
 century clinical research.  
Professional organizations providing clinical research 
certification currently require a minimum of two-years of 
experience to qualify for certification exams. Those 
organizations and individuals could use these indices to 
assess the readiness of candidates to sit for these 
examinations. These indices could also be used by 
institutions offering certified educational programs in 
clinical research to justify to these certification agencies 
that formal education can and should be substituted for 
some fraction of time currently required in on-the-job-
training. This would shorten the time from entry into the 
workforce and certification in a clinical research 
profession that could help alleviate existing workforce 
shortages.  
We recognize important limitations of these data. First, 
the JTF data were collected via self- selection methods 
(i.e., Survey Monkey) and therefore respondents do not 
constitute a random sample of the clinical research 
workforce. Second, respondents self-identified their role 
in the workforce and there is ambiguity in the definition 
of clinical research roles. The potential for even greater 
role ambiguity between countries with varying regulatory 
systems is why we limited the analysis to respondents 
working in the US and Canada. Nevertheless, the variable 
role in the workforce remains subject to a degree of 
misclassification bias. Third, a number of respondents did 
not answer each of the three survey questions (i.e., 
competence to perform; significance for role; and need 
for further training) about each of the 51 core 
competencies. The lack of complete response, more than 
likely a result of „survey fatigue‟, resulted in case loss 
due to missing data for which there is no justification to 
assume „missing completely at random‟. To assess how 
problematic missing data is, we analyzed „missing‟ as a 
function of the respondent‟s role in the workfore, their 
years of experience in the CR enterprise and their level of 
education. The differences in non-response by CR role 
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were statistically significant (χ
2
=13.76, p=0.0174). 
Similarly, non-response rates differed by level of 
education (χ
2
=29.28; p<0.001). However, there were no 
statistically or meaningful differences in non response by 
years of experience in the CR enterprise. Accordingly, 
the analytical file under-represents those at the extremes 
of education and may over represent those in the CR 
worksforce with a masters degree. It must be noted, 
however, that we really do not know the proportion of 
workers in various roles, their years of experience or the 
educational levels of the CR workforce in the US or in 
Canada. Consequently, estimating the extent of bias in 
the analytical data file would be speculative at best. What 
we can say with some degree of confidence is that these 
data are the most comprehensive data available about 
how competent those employed in clinical research in the 
USA and Canada perceive themselves to be in their 




This analysis has created a psychometrically valid 
general Competency Index for Clinical Research 
Professionals” and competency indices for specialized 
functions in the research enterprise. The CICRP-General 
as well as the four 5 item subscales of competency in 
specialized activities in clinical research can be a 
valuable tool for sponsors, investigators, organizations 
involved in the education and training or workers who 
support principal investigators by implementing clinical 
trial protocols. Further studies that relate self-proclaimed 
competence in performing clinical research activities as 
measured by the CICRP indices with data that assesses 
observable performance and the relationships between 
competency, education and experience in the workforce 
are needed. 
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